Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Idorsia Pharmaceutical Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 20 Jul 2023 | Sosei Group Acquires Idorcia Pharmaceuticals Japan and Idorsia Pharmaceuticals Korea from Idorsia Pharma for Approximately USD466.05 Million | Acquisition |
Sosei Group Corp
|
Idorsia Pharmaceuticals Korea Co Ltd
Idorsia Pharmaceuticals Japan Ltd
|
| 26 Jun 2023 | Idorsia Pharmaceutical Ltd Enters Phase III Clinical Trial Agreement with Novotech Australia Pty Ltd for cenerimod (GDCT0475932) | Contract Service Agreement |
Idorsia Pharmaceutical Ltd
|
Novotech Australia Pty Ltd
|
| 23 Jun 2023 | Idorsia Pharmaceutical Ltd Enters Phase I Clinical Trial Agreement with Anaheim Clinical Trials-LLC for daridorexant hydrochloride (GDCT0489103) | Contract Service Agreement |
Idorsia Pharmaceutical Ltd
|
Anaheim Clinical Trials-LLC
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer